National Pharmaceutical Council announced that NPC This Week features sessions on navigating the CAR T-cell treatment journey, the cost of 340B to states, Florida PBM lawsuits, and more.
Published
Signal category
Presence & Recognition
Quote
“Today in NPC This Week: Navigating the CAR T-cell treatment journey, the cost of 340B to states, Florida PBM lawsuits, and more.”
— National Pharmaceutical Council team
Company
National Pharmaceutical Council
Policy-relevant research since 1953
- Industry
- Pharmaceutical Manufacturing
- Location
- Washington, US
- Company size
- 39 employees
NPC serves patients and society with policy-relevant research on the value of patient access to innovative medicines and the importance of scientific advancement. We envision a world where advances in medicine are accessible to patients, valued by society, and sustainably reimbursed by payers to ensure continued innovation. We provide the evidence to bolster the case for the value of innovation through our policy-relevant research. NPC informs policy discussions in the media, in Congressional testimony, and through leading voices sharing our research about the future of innovative medicine and patient access.
Founded 1953